Sign inJoin waitlistJoin the waitlist

PP

Paul Paik

Clinical Director, Thoracic Oncology Service · New York Presbyterian Hospital

Credentials: · · · ·

History

Thoracic Oncology Service · New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2008–2010
Internal Medicine
New York Presbyterian Hospital
2005–2008
Weill Cornell Medicine
2001–2005

Research

OncoKB: A Precision Oncology Knowledge Base
JCO Precision Oncology · 2017 · 2,318 citations
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
New England Journal of Medicine · 2020 · First of 35 authors · 717 citations
Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers
Clinical Cancer Research · 2012 · 550 citations

MK
Mark Kris
32 papers
ML
Marc Ladanyi
28 papers
GR
Gregory Riely
25 papers
Charles Rudin
20 papers
JC
Jamie Chaft
19 papers · 2 as a fellow
NR
Natasha Rekhtman
17 papers
HY
Helena Yu
14 papers · 1 as a fellow
AD
Alexander Drilon
13 papers
MA
Maria Arcila
13 papers · 1 as a fellow
MH
Matthew Hellmann
13 papers · 2 as a fellow
BL
Bob Li
11 papers
MO
Michael Offin
11 papers · 6 as a fellow

Grants

A Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Advanced NSCLC Patients
National Cancer Institute · R01
Contact PI · $1.8M · Sloan-Kettering Inst Can Research
2021–2026

Clinical trials

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2026–2029
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Principal investigator · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028
A Study of ZEN003694 in People With Squamous Cell Lung Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2026